We are live on
!
Find out more
MGB
Mass General Brigham Portfolio holdings
AUM
$361M
This Fund
S&P 500
This Quarter
Est. Return
+35.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57.1M
AUM Growth
+$29.1M
(+104%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
29.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
4
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$10M |
| 2 |
Pliant Therapeutics
PLRX
|
+$4.76M |
| 3 |
Tango Therapeutics
TNGX
|
+$3.8M |
| 4 |
Coinbase
COIN
|
+$2.03M |
| 5 |
Fulcrum Therapeutics
FULC
|
+$1.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$5.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 65.08% |
| 2 | Healthcare | 34.92% |
| 3 | Technology | 0% |
Similar funds
PI
PWC
MCM
RA
A6
WTFG
5VM
SIAG
Mass General Brigham's Q1 2024 Portfolio in Review
As of Q1 2024, Mass General Brigham held 6 positions worth $57.1M, up 104% from $28M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mass General Brigham deployed $16.9M of net new capital in Q1 2024, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Revolution Medicines: 338,191 shares worth $10.9M.
By sector, the portfolio is most concentrated in Financials at 65% of assets, down from 80% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the most notable exit was Snowflake, an estimated $5.59M sold.
- Mass General Brigham's largest Q1 2024 buy was Revolution Medicines: 338,191 shares worth $10.9M.
- Mass General Brigham added most to Coinbase in Q1 2024, an estimated $2.03M increase.
- Mass General Brigham fully exited Snowflake in Q1 2024, selling an estimated $5.59M.
- Mass General Brigham's ten largest holdings make up 100% of its $57.1M portfolio in Q1 2024.
- Mass General Brigham opened 4 new positions and closed 1 in Q1 2024.
- Mass General Brigham's portfolio value rose 104% quarter-over-quarter to $57.1M.
Based on Mass General Brigham's 13F filing for Q1 2024, filed 4 Apr 2024.